Table 1 Correlation between SOX2OT expression and clinicopathological features of UCB patients
Parameters Total | Group | Total | SOX2OT expression | P value | |
|---|---|---|---|---|---|
High | Low | ||||
Gender | Male | 79 (75%) | 56 (53%) | 23 (22%) | 0.751 |
Female | 27 (25%) | 20 (19%) | 7 (7%) | ||
Age (years) | <  60 | 37 (35%) | 26 (25%) | 11 (10%) | 0.811 |
≥ 60 | 69 (65%) | 50 (47%) | 19 (18%) | ||
Tumor size (cm) | <  3 cm | 42 (40%) | 26 (25%) | 16 (15%) | 0.071 |
≥ 3 cm | 64 (60%) | 50 (47%) | 14 (13%) | ||
Multiplicity | Single | 59 (56%) | 38 (36%) | 21 (20%) | 0.062 |
Multiple | 47 (44%) | 38 (36%) | 9 (8%) | ||
Histological grade | Low grade | 48 (45%) | 25 (24%) | 23 (22%) | 0.001 ** |
High grade | 58 (55%) | 51 (48%) | 7 (7%) | ||
Tumor stage (T) | Ta, T1 | 26 (25%) | 12 (11%) | 14 (13%) | 0.002 ** |
T2-T4 | 80 (75%) | 64 (60%) | 16 (15%) | ||
Lymph nodes metastasis | NO | 92 (87%) | 65 (61%) | 27 (25%) | 0.768 |
YES | 14 (13%) | 11 (10%) | 3 (3%) | ||